Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial.

Goss GD, Felip E, Cobo M, Lu S, Syrigos K, Lee KH, Göker E, Georgoulias V, Li W, Guclu S, Isla D, Min YJ, Morabito A, Ardizzoni A, Gadgeel SM, Fülöp A, Bühnemann C, Gibson N, Krämer N, Solca F, Cseh A, Ehrnrooth E, Soria JC.

JAMA Oncol. 2018 Jun 14. doi: 10.1001/jamaoncol.2018.0775. [Epub ahead of print]

PMID:
29902295
2.

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study.

Gadgeel S, Goss G, Soria JC, Felip E, Georgoulias V, Lu S, Cobo M, Syrigos K, Lee KH, Göker E, Guclu SZ, Isla D, Morabito A, Dupuis N, Bühnemann C, Krämer N, Solca F, Ehrnrooth E, Ardizzoni A.

Lung Cancer. 2017 Jul;109:101-108. doi: 10.1016/j.lungcan.2017.05.010. Epub 2017 May 11.

3.

Epithelial-mesenchymal transition and nuclear β-catenin induced by conditional intestinal disruption of Cdh1 with Apc is E-cadherin EC1 domain dependent.

Matheson J, Bühnemann C, Carter EJ, Barnes D, Hoppe HJ, Hughes J, Cobbold S, Harper J, Morreau H, Surakhy M, Hassan AB.

Oncotarget. 2016 Oct 25;7(43):69883-69902. doi: 10.18632/oncotarget.11513.

4.

Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis.

Bühnemann C, Li S, Yu H, Branford White H, Schäfer KL, Llombart-Bosch A, Machado I, Picci P, Hogendoorn PC, Athanasou NA, Noble JA, Hassan AB.

PLoS One. 2014 Sep 22;9(9):e107105. doi: 10.1371/journal.pone.0107105. eCollection 2014.

5.

Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy.

Zhang YX, van Oosterwijk JG, Sicinska E, Moss S, Remillard SP, van Wezel T, Bühnemann C, Hassan AB, Demetri GD, Bovée JV, Wagner AJ.

Clin Cancer Res. 2013 Jul 15;19(14):3796-807. doi: 10.1158/1078-0432.CCR-12-3647. Epub 2013 May 28.

6.

Maternal transmission of a humanised Igf2r allele results in an Igf2 dependent hypomorphic and non-viable growth phenotype.

Hughes J, Frago S, Bühnemann C, Carter EJ, Hassan AB.

PLoS One. 2013;8(2):e57270. doi: 10.1371/journal.pone.0057270. Epub 2013 Feb 28.

7.

Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.

Haley VL, Barnes DJ, Sandovici I, Constancia M, Graham CF, Pezzella F, Bühnemann C, Carter EJ, Hassan AB.

EMBO Mol Med. 2012 Aug;4(8):705-18. doi: 10.1002/emmm.201101105. Epub 2012 Jun 6.

8.

Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats.

Bühnemann C, Scholz A, Bernreuther C, Malik CY, Braun H, Schachner M, Reymann KG, Dihné M.

Brain. 2006 Dec;129(Pt 12):3238-48. Epub 2006 Oct 3.

PMID:
17018551
9.

Preparation of a tissue-like cortical primary culture from embryonic rats using Matrigel and serum free Start V Medium.

Braun H, Bühnemann C, Neumann J, Reymann KG.

J Neurosci Methods. 2006 Oct 15;157(1):32-8. Epub 2006 May 8.

PMID:
16682083

Supplemental Content

Loading ...
Support Center